Diabetes
Victoza
Active ingredient: Liraglutide · 1.8 mg/dose · pen · qty 2
No FDA-approved generic available — manufacturer savings card may cut cost 50%+
Daily GLP-1 for type 2 diabetes.
Live verified prices
Fetching live quotes…
Common uses & information
Victoza is a brand of Liraglutide, a diabetes medication supplied as pen in a 1.8 mg/dose strength. It is commonly used for daily GLP-1 for type 2 diabetes.
An FDA-approved generic (Liraglutide) is available and typically costs less than the brand — compare both cash prices in the table above before you fill.
Got questions?
Chat available now
Want to dig deeper on Victoza 1.8 mg/dose?
Ask about generic alternatives, coverage, dosing, or have an agent widen the search to other pharmacies near you.
Price summary
| Form | Class | Brand avg | Generic avg | Savings |
|---|---|---|---|---|
| pen 1.8 mg/dose | Specialty | $812.00 | $780.00 | — |
Clinical information
Clinical content reviewed by the BetterBuyRx clinical team. Read the full wiki entry and sources →
Manufacturer & patient assistance programs
FAQ
Is there a generic for Victoza?
Not yet. The FDA has not approved a generic equivalent for Victoza (Liraglutide). A manufacturer savings card from the brand maker is usually the largest legitimate discount available today.
How much can I save by choosing the generic?
Currently no FDA-approved generic equivalent exists for Victoza, so the brand and generic prices are similar.
Do I need insurance to get this price?
No. The prices shown on BetterBuyRx are cash prices. Often these beat insurance copays for generics.
How often is this price updated?
At minimum every 72 hours. Many sources refresh every few hours.
Related medications
Compare Victoza with other options and see the generic price.
Other drugs for Diabetes
Cheapest Victoza alternatives
Compare Victoza with…
Information for general comparison only. Not medical advice. Confirm with your pharmacist.
